Amputation of Upper Limb

3

Review clinical trials related to Amputation of Upper Limb. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain

The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: AtriCure, Inc.Updated: Jun 26, 2026Locations: 5Duration: 5 Years
Eligibility criteria

Patients who have or will have an amputation procedure; [+2]

Women of childbearing potential who are, or plan to become, pregnant during the... [+1]

Status: Recruiting

Using Sensorimotor Reorganization Following Upper Limb Amputation to Improve Prosthetic Control

Amputation of an upper limb results in a disruption of the sensorimotor loop and a reorganization of the nervous system, leading to the emergence of a phantom limb and the adaptation of compensatory motor strategies. This project aims to leverage these phenomena (induced sensations, phantom mobility, and compensations) to improve control, sensory feedback, and the appropriation of prostheses, in order to reduce cognitive load and musculoskeletal disorders.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord EstUpdated: Jun 24, 2026Locations: 2
Eligibility criteria

people aged 18 or more [+3]

history of progressive psychiatric or neurological disorders or disorders with r... [+4]

Status: Recruiting

A Multicenter, Multinational, Cohort Long-term Post-market Clinical Follow-up (PMCF) of the Safety and Efficacy of the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System When Used for Transhumeral Implantation in Amputee Patients

This non-interventional clinical investigation is initiated for the purpose of long-term Post-Market Clinical Follow-up (PMCF) and the follow-up time of patients is expected to span from 6 months to \>20 years in function. It will collect and evaluate clinical data on the safety and performance of the OPRA™ Implant System when used on transhumeral amputees and within the scope of the intended use.

Participants needed: 70
Trial details
Biological sex: AllType: InterventionalSponsor: IntegrumUpdated: Jul 3, 2025Locations: 6
Eligibility criteria

Unilateral or bilateral amputation [+2]

Subject not willing to consent [+1]